Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 574

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction

Open access
Perera, Divaka, Clayton, Tim, O’Kane, Peter D., Greenwood, John P., Weerackody, Roshan, Ryan, Matthew, Morgan, Holly P., Dodd, Matthew, Evans, Richard, Canter, Ruth, Arnold, Sophie, Dixon, Lana J., Edwards, Richard J., De Silva, Kalpa, Spratt, James C., Conway, Dwayne, Cotton, James, McEntegart, Margaret, Chiribiri, Amedeo, Saramago, Pedro, Gershlick, Anthony, Shah, Ajay M., Clark, Andrew L., Petrie, Mark C.·2022·New England Journal of Medicine

Abstract

BACKGROUND: Whether revascularization by percutaneous coronary intervention (PCI) can improve event-free survival and left ventricular function in patients with severe ischemic left ventricular systolic dysfunction, as compared with optimal medical therapy (i.e., individually adjusted pharmacologic and device therapy for heart failure) alone, is unknown. METHODS: We randomly assigned patients with a left ventricular ejection fraction of 35% or less, extensive coronary artery disease amenable to PCI, and demonstrable myocardial viability to a strategy of either PCI plus optimal medical therapy (PCI group) or optimal medical therapy alone (optimal-medical-therapy group). The primary composite outcome was death from any cause or hospitalization for heart failure. Major secondary outcomes were left ventricular ejection fraction at 6 and 12 months and quality-of-life scores. RESULTS: A total of 700 patients underwent randomization - 347 were assigned to the PCI group and 353 to the optimal-medical-therapy group. Over a median of 41 months, a primary-outcome event occurred in 129 patients (37.2%) in the PCI group and in 134 patients (38.0%) in the optimal-medical-therapy group (hazard ratio, 0.99; 95% confidence interval [CI], 0.78 to 1.27; P = 0.96). The left ventricular ejection fraction was similar in the two groups at 6 months (mean difference, -1.6 percentage points; 95% CI, -3.7 to 0.5) and at 12 months (mean difference, 0.9 percentage points; 95% CI, -1.7 to 3.4). Quality-of-life scores at 6 and 12 months appeared to favor the PCI group, but the difference had diminished at 24 months. CONCLUSIONS: Among patients with severe ischemic left ventricular systolic dysfunction who received optimal medical therapy, revascularization by PCI did not result in a lower incidence of death from any cause or hospitalization for heart failure. (Funded by the National Institute for Health and Care Research Health Technology Assessment Program; REVIVED-BCIS2 ClinicalTrials.gov number, NCT01920048.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2206606

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 574

Metadata

Authors
Perera, D., Clayton, T., O’Kane, P. D., Greenwood, J. P., Weerackody, R., Ryan, M., Morgan, H. P., Dodd, M., Evans, R., Canter, R., Arnold, S., Dixon, L. J., Edwards, R. J., De Silva, K., Spratt, J. C., Conway, D., Cotton, J., McEntegart, M., Chiribiri, A., Saramago, P., Gershlick, A., Shah, A. M., Clark, A. L., & Petrie, M. C.
Venue
New England Journal of Medicine
Published
2022-10-13
Volume
387
Issue
15
Pages
1351-1360
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4293364542
Cited by
574
References
17
FWCI
104.07
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. https://app.cochat.ai/papers/10.1056/nejmoa2206606
The paper
Perera, D., Clayton, T., O’Kane, P. D., Greenwood, J. P., Weerackody, R., Ryan, M., Morgan, H. P., Dodd, M., Evans, R., Canter, R., Arnold, S., Dixon, L. J., Edwards, R. J., De Silva, K., Spratt, J. C., Conway, D., Cotton, J., McEntegart, M., Chiribiri, A., . . . Petrie, M. C. (2022). Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2206606

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.